Masterclass Certificate in Signal Transduction and Drug Design
-- ViewingNowThe Masterclass Certificate in Signal Transduction and Drug Design is a comprehensive course that equips learners with essential skills in drug discovery and design. This program emphasizes the importance of signal transduction in understanding diseases and developing effective therapeutic strategies.
5,932+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Fundamentals of Signal Transduction: An introduction to the basic principles and mechanisms of signal transduction, including receptor-ligand interactions and intracellular signaling pathways.
⢠Molecular Pharmacology: An exploration of the interactions between drugs and their molecular targets, focusing on the principles of drug action, receptor theory, and pharmacodynamics.
⢠Advanced Signal Transduction Pathways: A deep dive into the intricacies of various signal transduction pathways, such as G-protein-coupled receptors, tyrosine kinase receptors, and second messenger systems.
⢠Computational Approaches in Drug Design: An overview of computational methods used in drug discovery, including molecular modeling, molecular dynamics simulations, and quantitative structure-activity relationship (QSAR) analysis.
⢠High-throughput Screening and Assay Development: A survey of high-throughput screening techniques and assay development strategies for drug discovery, including automation, miniaturization, and data analysis.
⢠Drug Disposition, Pharmacokinetics, and Pharmacodynamics: A study of the factors that influence drug disposition and pharmacokinetics, including absorption, distribution, metabolism, and excretion, as well as the relationship between drug concentration and effect.
⢠Novel Approaches in Signal Transduction and Drug Design: An examination of emerging trends and technologies in signal transduction and drug design, such as allosteric modulation, targeted protein degradation, and personalized medicine.
⢠Regulatory Affairs and Intellectual Property in Drug Development: An overview of the regulatory landscape for drug development, including the role of regulatory agencies, clinical trials, and intellectual property protection.
ę˛˝ë Ľ 경ëĄ
ę˛˝ë Ľ ę˛˝ëĄ ěěą ě¤...
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
